Journal
CANCER DISCOVERY
Volume 6, Issue 2, Pages 128-129Publisher
AMER ASSOC CANCER RESEARCH
DOI: 10.1158/2159-8290.CD-15-1501
Keywords
-
Categories
Funding
- NCI NIH HHS [P30 CA008748, R01 CA154767, R01 CA177828] Funding Source: Medline
Ask authors/readers for more resources
Peng and colleagues describe the effects of PTEN inactivation on antitumor immunity and response to immune checkpoint blockade in melanoma. These results shed light on the intricate interplay between oncogenic pathways and antitumor immune response. (C) 2016 AACR.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
